Today, Samsung has announced that the IHRN or Irregular Heart Rhythm Notification component of the ECG feature on the Galaxy Watch series is finally cleared by FDA. This means that supported Galaxy Watches will be able to use the BioActive sensor on the devices to look for any early signs of atrial fibrillation or Afib. The feature will be debuting on the Galaxy Watch 6 that is scheduled for later this year.

Galaxy Watch 6 will be the first watch to offer FDA-approved Irregular Heart Rhythm Notifications, with older Galaxy Watches to follow

However, the company has mentioned that the feature would also come on older Galaxy Watches. Basically, if your Galaxy Watch supports One UI 5 Watch, then you do not have to worry about it as the feature would be available. However, we cannot say much about what the Galaxy Watch 6 will bring to the table.

Thankfully, Samsung has mentioned that this FDA-approved IHRN method will actually be available on older watches once the Galaxy Watch 6 debuts. The South Korean tech giant talks about how once you have activated this feature in the Samsung Health Monitor app, the IHRN feature will check for irregular heart rhythms in the background using the BioActive sensor found on the watches.

For those wondering, the BioActive sensor has been around since the Galaxy Watch 4, which means that even if you own the older variant, you will not need to upgrade to the Galaxy Watch 6 to use the IHRN system.

As for the Galaxy Watch 6, you will have to wait until later this year when Samsung will officially unveil the new watches and other devices, hopefully in July, along with the new foldable phones later this year. The point is that the new smartwatches are coming and will be bringing a whole host of improvements and features that are not available on other offerings in the market. Not just that, Samsung has committed that it will be providing the same support to older devices, too. So, you do not have to worry much in the first place.

Source: Samsung Newsroom